Stock Events

Stock Events

Vanda Pharmaceuticals (VNDA) Q1 2025 Earnings

13FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.19

-0.11

-0.03

0.05

Details

Expected EPS

-0.106667

Actual EPS

-0.08

Surprise EPS

0.03

Surprise Percent

+25%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -0.08 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.